Coalition principles regarding the uptake of biosimilars
Published: Sep 1, 2019
Tagged in: Biosimilars, Access to Affordable Medicines
For decades, NORD has pursued federal and state policies that will change the lives of Americans impacted by rare diseases for the better. NORD’s work can be viewed below. This page is updated daily to provide timely information. Please contact us if you have questions or need additional information.
Coalition principles regarding the uptake of biosimilars
Published: Sep 1, 2019
Tagged in: Biosimilars, Access to Affordable Medicines
Coalition letter to Congress in support of a provision to increase the uptake of biosimilars
Published: Jul 3, 2019
Tagged in: Biosimilars, Access to Affordable Medicines
NORD comments to FDA regarding innovation and competition in the biological products marketplace
Published: Sep 21, 2018
Tagged in: Biosimilars, Access to Affordable Medicines
NORD letter in support of New Hampshire House Bill 1791, an act calling for prescriber communication with regard to biosimilars
Published: May 23, 2018
Tagged in: Biosimilars, Access to Affordable Medicines
NORD letter in support of West Virginia House Bill 4524, an act calling for prescriber communication with regard to biosimilars
Published: Mar 26, 2018
Tagged in: Biosimilars, Access to Affordable Medicines
Coalition letter to Congress regarding a desire for a hearing on ensuring patient safety and access in the midst of the Biologics Price Competition and Innovation Act (BPCIA)
Published: Jan 30, 2018
Tagged in: Biosimilars, Access to Affordable Medicines